CRF Health's Technology Recognized By Deloitte And Listed On Their 2012 Fast 500
CRF Health, the developer of the TrialMax® Suite of electronic Clinical Outcome Assessment Solutions (eCOA) for the life sciences industry, was named to the 2012 edition of the Deloitte’s Technology Fast 500™ for their proprietary intellectual technology. The TrialMax® Suite of eCOA solutions enables the collection, management and near real time visibility of clinical research data reported directly from patients, clinical observers and investigators.
By leveraging the TrialMax® Suite, the most innovative pharmaceutical companies have accelerated nearly 400 clinical trials compared to paper-based trials by increasing patient compliance, improving data quality and reliability with near real time visibility to outcome data.
“We are excited that Deloitte has recognized CRF Health’s growth and commitment to supporting our clients’ research. It is only through our team’s regulatory rigor, technology competence and patient engagement proficiency that enable us to combine clinical expertise and innovation,” commented Rachael Wyllie, CEO in her internal announcement of the award.
“We are proud to honor the 2012 Technology Fast 500™ companies, and commend them for their outstanding growth,” said Eric Openshaw, vice chairman, Deloitte LLP and U.S. technology, media and telecommunications (TMT) leader. "These ground-breaking companies have outpaced their competition and are reinventing the way we do business today.”
About Deloitte's 2012 Technology Fast 500™
Technology Fast 500, conducted by Deloitte & Touche LLP, provides a ranking of the fastest growing technology, media, telecommunications, life sciences and clean technology companies – both public and private - in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2007 to 2011.
About CRF Health
CRF Health supports the adoption of electronic Clinical Outcome Assessments (eCOA) solutions in global clinical trials. The most innovative Pharmaceutical and Biotechnology companies partner with CRF Health to develop Clinical Outcome Assessment strategies, transition from legacy paper instruments, and manage Clinical Outcome data to gain immediate visibility to patient assessments.
By means of our expertise, technologies and service we bridge the barriers to securely deliver eCOA solutions for the life sciences industry.
CRF Health has managed nearly 400 clinical trials in over 70 countries and 68 regional languages; consistently demonstrating the industry’s highest patient compliance rates, while delivering data accuracy and unmatched patient and site acceptance.
SOURCE: CRF Health